Xtampza ER

Drug Details

Xtampza ER, a form of oxycodone, is an extended-release opioid medication designed for managing severe, persistent pain, such as that experienced in cancer, which cannot be alleviated by non-opioid medications. This drug works by binding to mu-opioid receptors in the brain, altering the perception and response to pain. It is intended for patients who require continuous, long-term pain management and have been accustomed to opioid treatments. It is crucial not to use Xtampza ER for mild or short-term pain, nor is it suitable for occasional, as-needed use. The medication should be taken orally every 12 hours. Since it is a controlled substance, there is a risk of misuse and dependence. Patients should be aware of potential side effects, which include nausea, headache, and constipation. Always consult healthcare professionals before starting or changing dosage, as higher doses can pose serious risks, including overdose, particularly in individuals not accustomed to regular opioid use.